adjust ep exclud certain amort restructur one-tim item
zoeti locat parsippani nj world largest anim health compani medicin product
august zoeti report better-than-expect result revenu adjust ep
vs rais estim reflect strong result improv full-year outlook
expect ep previous grow previous
drive revenu growth companion anim revenu grew includ organ growth ex-fx
abaxi dermatolog sale grew zoeti expect apoquel/cytopoint portfolio
surpass sale year compani also see growth simparica
newli launch revolut compani also highlight futur growth opportun recent fda
approv once-yearli heartworm inject dog posit opinion eu simparica
trio triple-combo parasiticid file new pain product cat potenti launch
livestock return growth livestock revenu grew oper exclud fx impact
despit continu pressur us cattl market intern swine market due african swine fever
asf compani grew oper speci poultri lead way asf
estim neg impact quarter contribut oper declin china full
year asf expect neg impact revenu
updat estim rais revenu adjust ep estim
follow strong result expect adjust ep grow
per share
maintain hold recommend zoeti base sole valuat compani continu execut
across speci geographi expect sharehold continu reward manag team
consist prove among best across entir healthcar landscap howev believ
compani current valuat ebitda ep adequ reflect compani leadership
posit attract cash-pay anim health market
million except per share
exclud certain non-cash item restructur certain one-tim item
compani file research estim
million except per share
current market discount pmv
after-tax payment buy option pmv
compani file research estim
kevin kedra research analyst prepar report herebi certifi view express report accur reflect
analyst person view subject compani secur research analyst receiv
direct indirect compens express specif recommend view report
public data august rate buy
chang hold may
